In a recent published report, Kenneth Research has updated the market report for Preimplantation Genetic Diagnosis (PGD) Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Preimplantation Genetic Diagnosis (PGD) Market products.
Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10325475
Moreover, the median health expenditure per capita recorded in the high-income, upper-middle income, and low & lower-middle income countries, recorded to be over USD 2,000, USD 400, and USD 100 respectively. Additionally, in the same year, the spending on health in high-income countries and in the low- and middle-income countries comprised approximately 8.2% and 6.3% of the GDP respectively.
“Final Report will add the analysis of the impact of COVID-19 on this industry.”
Global Preimplantation Genetics Diagnosis (PGD) Market is estimated to reach $140 Million by 2024; growing at a CAGR of 6.2% from 2016 to 2024. Preimplantation genetic diagnosis is a procedure which involves genetic profiling of embryos, so as to reduce the possibility of passing on inherited disorders. It aids in detecting embryos with abnormalities and selects healthy embryo that can be used for implanting in the uterus. It decreases the rate of unprompted abortion and increased the probabilities of delivering genetically healthy baby. It majorly helps couples whose offspring are capable of getting affected by severe mendelian disorders, mitochondrial disorders or structural chromosome abnormalities. Presently, PGD is the only available technique which are used to avoid highly affected embryo before implantation.
The factors driving the global preimplantation genetics diagnosis (PGD) market includes decreasing fertility rate, technological advancements in the field of genetic analysis, rising demand for IVF treatments, increasing commonness of genetic disorders, and risk of affecting genetic disorders in embryos with increasing maternal age. Though, ethical and economic concerns and several government regulations would hinder the growth of the market. Furthermore, technological advancements and untapped markets would provide numerous growth opportunities in the forecast period.
“Final Report will add the analysis of the impact of COVID-19 on this industry.”
The global preimplantation genetics diagnosis (PGD) is segmented on the basis of test type and geography. Test type is further bifurcated as X-linked diseases, HLA typing, chromosomal abnormalities, gender selection, single gene disorders, aneuploidy, and other test types.
Based on geography, global market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is further bifurcated in U.S., Canada, and Mexico whereas Europe consist of UK, Germany, France, and others. Asia-Pacific is segmented into India, China, Japan, and others, while RoW is bifurcated into South America, Middle East and Africa.
Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10325475
The key market players include Thermo Fisher Scientific, Inc., Cooper Surgical, Inc., Abbott Laboratories, Agilent Technologies, Inc., Natera, Inc., PerkinElmer, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., PerkinElmer, Inc., and Beijing Genomics Institute (BGI), among others.
The key takeaways from the report
The report will provide detailed analysis of Preimplantation Genetics Diagnosis (PGD) Market with respect to major segments such as test type, and geography. The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024. Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
An exhaustive regional analysis of Preimplantation Genetics Diagnosis (PGD) Market has been included in the report. Profile of the key players in the Preimplantation Genetics Diagnosis (PGD) Market will be provided, which include key financials, product & services, new developments and business strategies
Scope of Preimplantation Genetics Diagnosis (PGD) Market
Test Type Segments:
X-Linked Diseases
HLA Typing
Chromosomal Abnormalities
Gender Selection
Single Gene Disorders
Aneuploidy
Other Test Types
Geographical Segments
Request Free Sample Copy :-https://www.kennethresearch.com/sample-request-10325475
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Others
Asia Pacific
India
China
Japan
Others
RoW
South America
Middle East
Africa
Table of Contents
Chapter 1 Prefix
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
3.1 Market Inclination, Trend, Outlook and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Impact Analysis
3.3.2 Restraints
3.3.2.1 Impact Analysis
3.3.3 Opportunities
Chapter 4 Preimplantation Genetics Diagnosis (PGD) Market by Test Type: Market Size and Forecast, 2015 – 2024
4.1 Overview
4.2 Gender Selection
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast
4.3 Chromosomal Abnormalities
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast
4.4 Single Gene Disorders
4.4.1 Current Trend and Analysis
4.4.2 Market Size and Forecast
4.5 HLA Typing
4.5.1 Current Trend and Analysis
4.5.2 Market Size and Forecast
4.6 Aneuploidy
4.6.1 Current Trend and Analysis
4.6.2 Market Size and Forecast
4.7 X-Linked Diseases
4.7.1 Current Trend and Analysis
4.7.2 Market Size and Forecast
4.8 Other Test Types
4.8.1 Current Trend and Analysis
4.8.2 Market Size and Forecast
About Kenneth Research:
Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.
Contact Us
Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609
————————New Latest Trending Reports——————————
